LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 40 of 497
Next
>>
>
976 to 1000 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Selumetinib	0.37	uM	LJP6	1	M10	72	hr	1097	3682	3769	0.9768	0.9672
BT-20	Selumetinib	0.37	uM	LJP6	2	M10	72	hr	1097	3431	3769	0.9102	0.8733
BT-20	Selumetinib	0.37	uM	LJP6	3	M10	72	hr	1097	3500	3769	0.9285	0.8991
BT-20	Sirolimus	0.37	uM	LJP6	1	L16	72	hr	1097	2251	3769	0.5972	0.4317
BT-20	Sirolimus	0.37	uM	LJP6	2	L16	72	hr	1097	2099	3769	0.5568	0.3749
BT-20	Sirolimus	0.37	uM	LJP6	3	L16	72	hr	1097	2209	3769	0.5860	0.4160
BT-20	Sorafenib	0.37	uM	LJP6	1	B10	72	hr	1097	3202	3769	0.8494	0.7876
BT-20	Sorafenib	0.37	uM	LJP6	2	B10	72	hr	1097	3286	3769	0.8717	0.8191
BT-20	Sorafenib	0.37	uM	LJP6	3	B10	72	hr	1097	2662	3769	0.7062	0.5856
BT-20	SU11274	0.37	uM	LJP5	1	J10	72	hr	1097	3940	3769	1.0452	1.0638
BT-20	SU11274	0.37	uM	LJP5	2	J10	72	hr	1097	3881	3769	1.0296	1.0417
BT-20	SU11274	0.37	uM	LJP5	3	J10	72	hr	1097	3919	3769	1.0396	1.0559
BT-20	Fedratinib	0.37	uM	LJP5	1	L04	72	hr	1097	3574	3769	0.9481	0.9268
BT-20	Fedratinib	0.37	uM	LJP5	2	L04	72	hr	1097	3642	3769	0.9662	0.9523
BT-20	Fedratinib	0.37	uM	LJP5	3	L04	72	hr	1097	3401	3769	0.9022	0.8621
BT-20	TGX221	0.37	uM	LJP5	1	H22	72	hr	1097	3712	3769	0.9847	0.9785
BT-20	TGX221	0.37	uM	LJP5	2	H22	72	hr	1097	3770	3769	1.0001	1.0002
BT-20	TGX221	0.37	uM	LJP5	3	H22	72	hr	1097	3988	3769	1.0580	1.0818
BT-20	Torin1	0.37	uM	LJP6	1	O16	72	hr	1097	965	3769	0.2560	-0.0495
BT-20	Torin1	0.37	uM	LJP6	2	O16	72	hr	1097	942	3769	0.2499	-0.0581
BT-20	Torin1	0.37	uM	LJP6	3	O16	72	hr	1097	1111	3769	0.2947	0.0051
BT-20	Torin2	0.37	uM	LJP5	1	I22	72	hr	1097	719	3769	0.1907	-0.1416
BT-20	Torin2	0.37	uM	LJP5	2	I22	72	hr	1097	801	3769	0.2125	-0.1109
BT-20	Torin2	0.37	uM	LJP5	3	I22	72	hr	1097	794	3769	0.2106	-0.1135
BT-20	Tozasertib	0.37	uM	LJP5	1	B16	72	hr	1097	1193	3769	0.3165	0.0358

|<
<<
Previous
Page 40 of 497
Next
>>
>
976 to 1000 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)